目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key objectives of secondary research
2.1.1.2 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key primary sources
2.1.2.2 Key objectives of primary research
2.1.2.3 Key industry insights
2.1.2.4 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
2.2.2 TOP-DOWN APPROACH
2.2.3 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS
2.2.4 DEMAND-SIDE ANALYSIS (USING RIGID ENDOSCOPES)
2.3 DATA TRIANGULATION
2.4 MARKET RANKING ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 RIGID ENDOSCOPES MARKET OVERVIEW
4.2 NORTH AMERICA: RIGID ENDOSCOPES MARKET, BY END USER AND COUNTRY
4.3 RIGID ENDOSCOPES MARKET: GEOGRAPHIC MIX
4.4 RIGID ENDOSCOPES MARKET: EMERGING VS. DEVELOPED ECONOMIES

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing preference for minimally invasive surgeries
5.2.1.2 Increasing burden of chronic and lifestyle-related diseases
5.2.2 RESTRAINTS
5.2.2.1 High overhead costs
5.2.2.2 Risk of viral infections during endoscopic procedures
5.2.3 OPPORTUNITIES
5.2.3.1 Rapidly developing healthcare sector in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Product recalls
5.2.4.2 Lack of sterilization and reprocessing
5.3 INDUSTRY TRENDS
5.3.1 ADVANCED IMAGING TECHNOLOGIES
5.3.2 MINIATURIZATION AND ULTRA-SLIM DESIGNS
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
5.5 PRICING ANALYSIS
5.5.1 AVERAGE SELLING PRICE TREND A OF RIGID ENDOSCOPES, BY KEY PLAYER, 2022-2024
5.5.2 AVERAGE PRICING TREND OF RIGID ENDOSCOPES, BY REGION, 2022-2024
5.6 VALUE CHAIN ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
5.8 ECOSYSTEM ANALYSIS
5.9 INVESTMENT & FUNDING SCENARIO
5.10 TECHNOLOGY ANALYSIS
5.10.1 KEY TECHNOLOGIES
5.10.1.1 Illumination technology
5.10.2 COMPLEMENTARY TECHNOLOGIES
5.10.2.1 Surgical visualization
5.10.3 ADJACENT TECHNOLOGIES
5.10.3.1 3D endoscopic visualization
5.11 TRADE ANALYSIS
5.11.1 IMPORT DATA FOR HS CODE 9018, 2019-2024
5.11.2 EXPORT DATA FOR HS CODE 9018, 2019-2024
5.12 REGULATORY ANALYSIS
5.12.1 REGULATORY LANDSCAPE
5.12.1.1 North America
5.12.1.1.1 US
5.12.1.1.2 Canada
5.12.1.2 Europe
5.12.1.3 Asia Pacific
5.12.1.3.1 Japan
5.12.1.3.2 China
5.12.1.3.3 India
5.12.1.4 Latin America
5.12.1.5 Middle East & Africa
5.12.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.13 PATENT ANALYSIS
5.13.1 PATENT PUBLICATION TREND
5.13.2 JURISDICTION AND TOP APPLICANT ANALYSIS
5.13.3 LIST OF PATENTS
5.14 KEY CONFERENCES & EVENTS, 2025-2026
5.15 PORTER'S FIVE FORCES ANALYSIS
5.15.1 THREAT OF NEW ENTRANTS
5.15.2 THREAT OF SUBSTITUTES
5.15.3 BARGAINING POWER OF BUYERS
5.15.4 BARGAINING POWER OF SUPPLIERS
5.15.5 INTENSITY OF COMPETITIVE RIVALRY
5.16 KEY STAKEHOLDERS & BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.16.2 BUYING CRITERIA
5.17 ADJACENT MARKET ANALYSIS
5.17.1 FLEXIBLE ENDOSCOPES MARKET
5.18 UNMET NEEDS/END-USER EXPECTATIONS
5.19 IMPACT OF AI/GEN AI ON RIGID ENDOSCOPES MARKET
5.19.1 INTRODUCTION
5.19.2 AI USE CASES
5.19.3 KEY COMPANIES IMPLEMENTING AI
5.19.4 FUTURE OF GENERATIVE AI ON RIGID ENDOSCOPES MARKET
5.20 IMPACT OF 2025 US TARIFFS ON RIGID ENDOSCOPES MARKET
5.20.1 INTRODUCTION
5.20.2 KEY TARIFF RATES
5.20.3 PRICE IMPACT ANALYSIS
5.20.4 IMPACT ON REGION
5.20.4.1 North America
5.20.4.2 Europe
5.20.4.3 Asia Pacific
5.20.5 IMPACT ON END-USE INDUSTRY

6 RIGID ENDOSCOPES MARKET, BY TYPE
6.1 INTRODUCTION
6.2 LAPAROSCOPES
6.2.1 RISING GLOBAL PREVALENCE OF GYNECOLOGICAL AND CANCER CONDITIONS TO PROPEL MARKET GROWTH
6.3 UROLOGY ENDOSCOPES
6.3.1 RISING UROLOGICAL DISORDERS AND TECHNOLOGICAL ADVANCES TO DRIVE GROWTH IN UROLOGY ENDOSCOPES SEGMENT
6.4 GYNECOLOGY ENDOSCOPES
6.4.1 INCREASING PREVALENCE OF GYNECOLOGICAL CANCERS AMONG WOMEN TO AID MARKET GROWTH
6.5 ARTHROSCOPES
6.5.1 RISING GERIATRIC POPULATION AND GROWING INCIDENCE OF ORTHOPEDIC DISEASES TO BOOST MARKET GROWTH
6.6 CYSTOSCOPES
6.6.1 RISING BLADDER CANCER CASES AND MINIMALLY INVASIVE BENEFITS TO DRIVE CYSTOSCOPES MARKET GROWTH
6.7 NEUROENDOSCOPES
6.7.1 RISING NEUROLOGICAL DISORDERS AND INVESTMENTS IN ADVANCED CARE TO DRIVE MARKET GROWTH
6.8 OTHER RIGID ENDOSCOPES

7 RIGID ENDOSCOPES MARKET, BY CLINICAL USAGE
7.1 INTRODUCTION
7.2 SURGICAL USAGE
7.2.1 RISING ADOPTION OF MINIMALLY INVASIVE SURGERIES TO DRIVE SEGMENTAL GROWTH
7.3 DIAGNOSTIC USAGE
7.3.1 GROWING DEMAND FOR OFFICE-BASED ENT, GYNECOLOGY, AND UROLOGY PROCEDURES TO ACCELERATE GROWTH

8 RIGID ENDOSCOPES MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 LAPAROSCOPY
8.2.1 BROAD CLINICAL APPLICABILITY AND STRONG PROCEDURAL DEMAND ACROSS DIAGNOSTIC AND THERAPEUTIC INTERVENTIONS TO AID GROWTH
8.3 UROLOGY ENDOSCOPY
8.3.1 RISING PREVALENCE OF URINARY TRACT DISEASES AND CANCERS TO FUEL MARKET
8.4 ARTHROSCOPY
8.4.1 INCREASING PREVALENCE OF ARTHRITIS AMONG AGING POPULATION TO SPUR GROWTH
8.5 NEUROENDOSCOPY
8.5.1 FAVORABLE GOVERNMENT AND PRIVATE SECTOR POLICIES TO SUPPORT ADOPTION OF NEUROENDOSCOPES
8.6 OTHER APPLICATIONS

9 RIGID ENDOSCOPES MARKET, BY END USER
9.1 INTRODUCTION
9.2 HOSPITALS
9.2.1 ROBUST SURGICAL INFRASTRUCTURE AND LARGE PATIENT BASE TO FOSTER GROWTH
9.3 AMBULATORY SURGERY CENTERS
9.3.1 GROWING PREFERENCE FOR OUTPATIENT SURGERIES AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
9.4 CLINICS
9.4.1 RISING ADOPTION OF OUTPATIENT DIAGNOSTICS AND DECENTRALIZED HEALTHCARE TO AID GROWTH
9.5 OTHER END USERS

10 RIGID ENDOSCOPES MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
10.2.2 US
10.2.2.1 US to dominate North American rigid endoscopes market during forecast period
10.2.3 CANADA
10.2.3.1 Rising chronic disease prevalence among aging population to drive market
10.3 EUROPE
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
10.3.2 GERMANY
10.3.2.1 Germany to dominate European rigid endoscopes market
10.3.3 UK
10.3.3.1 Increased aging population, high cancer prevalence, and strong healthcare infrastructure to drive market growth
10.3.4 FRANCE
10.3.4.1 Increase in health expenditure and high prevalence of cancer to stimulate market growth
10.3.5 ITALY
10.3.5.1 Increasing prevalence of chronic diseases to boost adoption
10.3.6 SPAIN
10.3.6.1 Rising aging population to drive market growth
10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
10.4.2 CHINA
10.4.2.1 China to dominate Asia Pacific rigid endoscopes market during forecast period
10.4.3 JAPAN
10.4.3.1 Increasing chronic disease prevalence and rising geriatric population to drive growth
10.4.4 INDIA
10.4.4.1 Rising osteoarthritis and cancer prevalence to drive market growth
10.4.5 AUSTRALIA
10.4.5.1 Advancing healthcare infrastructure to support rigid endoscopes adoption in Australia
10.4.6 SOUTH KOREA
10.4.6.1 Super-aged society and high disease prevalence to drive growth in South Korean market
10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
10.5.2 BRAZIL
10.5.2.1 Brazil to account for largest share of Latin American market
10.5.3 MEXICO
10.5.3.1 Increasing minimally invasive procedures to support rigid endoscopes adoption
10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
10.6.2 GCC COUNTRIES
10.6.2.1 High healthcare investments and hospital expansions to drive market growth
10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RIGID ENDOSCOPES MARKET
11.3 REVENUE ANALYSIS, 2020-2024
11.4 MARKET SHARE ANALYSIS, 2024
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
11.5.5.1 Company footprint
11.5.5.2 Region footprint
11.5.5.3 Type footprint
11.5.5.4 Application footprint
11.5.5.5 End-user footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
11.6.5.1 Detailed list of key startups/SMEs
11.6.5.2 Competitive benchmarking of key startups/SMEs
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES
11.9.2 DEALS

12 COMPANY PROFILES
12.1 KEY PLAYERS
12.1.1 OLYMPUS CORPORATION
12.1.1.1 Business overview
12.1.1.2 Products offered
12.1.1.3 Recent developments
12.1.1.3.1 Deals
12.1.1.4 MnM view
12.1.1.4.1 Right to win
12.1.1.4.2 Strategic choices
12.1.1.4.3 Weaknesses & competitive threats
12.1.2 KARL STORZ SE & CO. KG
12.1.2.1 Business overview
12.1.2.2 Products offered
12.1.2.3 Recent developments
12.1.2.3.1 Product launches
12.1.2.3.2 Deals
12.1.2.4 MnM view
12.1.2.4.1 Right to win
12.1.2.4.2 Strategic choices
12.1.2.4.3 Weaknesses & competitive threats
12.1.3 STRYKER
12.1.3.1 Business overview
12.1.3.2 Products offered
12.1.3.3 MnM view
12.1.3.3.1 Right to win
12.1.3.3.2 Strategic choices
12.1.3.3.3 Weaknesses & competitive threats
12.1.4 SMITH+NEPHEW
12.1.4.1 Business overview
12.1.4.2 Products offered
12.1.4.3 MnM view
12.1.4.3.1 Right to win
12.1.4.3.2 Strategic choices
12.1.4.3.3 Weaknesses & competitive threats
12.1.5 B. BRAUN SE
12.1.5.1 Business overview
12.1.5.2 Products offered
12.1.5.3 MnM view
12.1.5.3.1 Right to win
12.1.5.3.2 Strategic choices
12.1.5.3.3 Weaknesses & competitive threat
12.1.6 MEDTRONIC
12.1.6.1 Business overview
12.1.6.2 Products offered
12.1.6.3 Recent developments
12.1.6.3.1 Deals
12.1.7 NIPRO
12.1.7.1 Business overview
12.1.7.2 Products offered
12.1.8 RICHARD WOLF GMBH
12.1.8.1 Business overview
12.1.8.2 Products offered
12.1.8.3 Recent developments
12.1.8.3.1 Deals
12.1.9 CONMED CORPORATION
12.1.9.1 Business overview
12.1.9.2 Products offered
12.1.10 ARTHREX, INC.
12.1.10.1 Business overview
12.1.10.2 Products offered
12.2 OTHER PLAYERS
12.2.1 FUJIFILM CORPORATION
12.2.2 HOLOGIC, INC.
12.2.3 SHANGRAO WS MEDTECH CO., LTD.
12.2.4 ATMOS MEDIZINTECHNIK GMBH & CO. KG
12.2.5 HENKE-SASS WOLF
12.2.6 RUDOLF MEDICAL GMBH + CO. KG
12.2.7 ENDOMED SYSTEMS GMBH
12.2.8 TELEFLEX INCORPORATED
12.2.9 INTEGRATED ENDOSCOPY
12.2.10 NEOSCOPE INC.
12.2.11 ECLERIS
12.2.12 NANCHANG WOEK MEDICAL TECHNOLOGY CO., LTD
12.2.13 KASHMIR SURGICAL WORKS
12.2.14 OPTOMIC
12.2.15 HIPP ENDOSKOP SERVICE GMBH

13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS